Maj Invest Holding A S lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 48.4% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 174,594 shares of the company’s stock after selling 163,916 shares during the quarter. HCA Healthcare makes up 3.8% of Maj Invest Holding A S’s investment portfolio, making the stock its 16th biggest position. Maj Invest Holding A S’s holdings in HCA Healthcare were worth $81,512,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of the stock. Capital World Investors boosted its stake in HCA Healthcare by 3.8% during the third quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock worth $2,113,662,000 after buying an additional 179,443 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in HCA Healthcare by 1.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after buying an additional 36,414 shares during the period. Viking Global Investors LP boosted its stake in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after buying an additional 690,773 shares during the period. Legal & General Group Plc lifted its position in shares of HCA Healthcare by 0.8% during the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock worth $479,267,000 after purchasing an additional 8,478 shares in the last quarter. Finally, Invesco Ltd. lifted its position in shares of HCA Healthcare by 1.1% during the third quarter. Invesco Ltd. now owns 1,100,929 shares of the company’s stock worth $469,216,000 after purchasing an additional 11,829 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.
Insiders Place Their Bets
In related news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares in the company, valued at $4,721,924.61. This trade represents a 16.06% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.50% of the stock is currently owned by company insiders.
HCA Healthcare Trading Down 0.1%
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the business posted $6.45 earnings per share. The business’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.
Wall Street Analyst Weigh In
HCA has been the topic of several research reports. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Argus reduced their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. The Goldman Sachs Group increased their price target on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Sanford C. Bernstein reduced their price target on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a research report on Tuesday, April 28th. Finally, Oppenheimer reduced their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $517.82.
Check Out Our Latest Stock Analysis on HCA
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
